Linked Life Data

18478195

Source:http://linkedlifedata.com/resource/pubmed/id/18478195

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-6-3
pubmed:abstractText
Malignant melanoma is one of the most common cancers accounting for 4-5% of all human malignancies and steadily increasing in incidence. The medical management of melanoma patients in Germany can be regarded as largely standardized based upon interdisciplinary guide lines. The results of adjuvant and especially palliative treatment of melanoma are unsatisfactory. Thus there is an urgent need for controlled clinical trials in order to optimize standard treatment approaches and to evaluate new drugs. The treatment of patients affected with high risk or metastatic melanoma within those clinical trials should be standard of care. This overview delineates the most important clinical trials currently conducted or planned in the adjuvant and palliative setting of melanoma treatment.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0017-8470
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
484-91
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Systemic treatment of melanoma. Current clinical trials].
pubmed:affiliation
Schwerpunktbereich Dermato-Onkologie und Operative Dermatologie, Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Deutschland. ahauschild@dermatology.uni-kiel.de
pubmed:publicationType
Journal Article, English Abstract, Review